Advisability of palliative resections in incurable advanced gastric cancer

Polski Przeglad Chirurgiczny/ Polish Journal of Surgery

Volumn 83, Issue 8, 2011, Pages 449-456

  Al Amawi, Tariq ^a   Świder Al Amawi, Małgorzata ^a   Halczak, Mirosław ^a   Wojtasik, Piotr ^a   Kładny, Józef ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

gastric cancer; non resection procedures; palliative resections

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HUMAN; KAPLAN MEIER METHOD; LAPAROTOMY; LENGTH OF STAY; LIVER TUMOR; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MORTALITY; OVARY TUMOR; PALLIATIVE THERAPY; PATHOLOGY; POLAND; POSTOPERATIVE COMPLICATION; PROGNOSIS; STATISTICS; STOMACH BYPASS; STOMACH TUMOR; SURVIVAL; SURVIVAL RATE;

ADULT; AGED; FEMALE; GASTRIC BYPASS; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; LAPAROTOMY; LENGTH OF STAY; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PALLIATIVE CARE; POLAND; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 80053940872     PISSN: 0032373X     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10035-011-0070-0     Document Type: Article

References (26)

1. Plummer M, Franceschi S, Muñoz : Epidemiology of gastric cancer. IARC Sci Publ. 2004; 157: 311-26.
2. Ferlay J, Shin HR, Bray F et al.: GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr
3. Krajowa Baza Danych Nowotworowych. Zakład Epidemiologii i Prewencji Nowotworów Centrum Onkologii - Instytut. http://www.onkologia. org.pl/pl/p/7/
4. Hartgrink HH, Jansen EP, van Grieken NC et al.: Gastric cancer. Lancet 2009; 374(9688): 477-90.
5. Samarasam I, Chandran BS, Sitaram V et al.: Palliative gastrectomy in advanced gastric cancer: is it worthwhile? ANZ J Surg 2006; 76(1-2): 60-63.
6. Bozzetti F, Bonfanti G, Audisio RA et al.: Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet 1987; 164(2): 151-54.
7. Haugstvedt T, Viste A, Eide GE i wsp. The survival benefit of resection in patients with advanced stomach cancer: the Norwegian multicenter experience. Norwegian Stomach Cancer Trial. World J Surg 1989; 13(5): 617-22.
8. Lawrence W J r, McNeer G: The effectiveness of surgery for palliation of incurable gastric cancer. Cancer 1958; 11(1): 28-32.
9. Swan R, Miner TJ: Current role of surgical therapy in gastric cancer. World J Gastroenterol 2006 21; 12(3): 372-79.
10. Doglietto GB, Pacelli F, Caprino P et al.: Palliative surgery for far-advanced gastric cancer: a retrospective study on 305 consecutive patients. Am Surg 1999; 65(4): 352-55.
11. Cunningham SC, Schulick RD: Palliative management of gastric cancer. Surg Oncol 2007; 16(4): 267-75.
12. Hartgrink HH, Putter H, Klein Kranenbarg E et al.: Dutch Gastric Cancer Group. Value of palliative resection in gastric cancer. Br J Surg 2002; 89(11): 1438-43.
13. Miner TJ, Jaques DP, Karpeh MS et al.: Defining palliative surgery in patients receiving noncurative resections for gastric cancer. J Am Coll Surg 2004; 198(6): 1013-21.
14. Saidi RF, ReMine SG, Dudrick PS et al.: Is there a role for palliative gastrectomy in patients with stage IV gastric cancer? World J Surg 2006; 30(1): 21-27.
15. Huang KH, Wu CW, Fang WL et al.: Palliative resection in noncurative gastric cancer patients. World J Surg 2010; 34(5): 1015-21.
16. Popiela T, Kulig J, Karcz D, Czupryna A: Zasady postêpowania chirurgicznego w raku żołâdka; zabiegi paliatywne. W: Popiela T (red.) Rak żołâdka. PZWL, Warszawa 1987; 7: 172-176.
17. Popiela T: Nowotwory zołâdka. W: Szawłowski A, Szmidt J (red.) Zasady diagnostyki i chirurgicznego leczenia nowotworów w Polsce. Fundacja PPCh 2003; 10: 190-94.
18. Okines A, Verheji M, Allum W, Cunnigham D, Cervantes A: ESMO Guidelines Working Group: Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 (suppl 5): v50-v54.
19. National Comprehensive Cancer Network. Gastric cancer NCCN clinical practice guidelines in oncology. 2011; version I.2011
20. Guyatt GH: Evidence-based medicine. ACP J Club (Annals of Internal Medicine) 1991; 114(suppl 2): A-16
21. Van Custem Ei wsp. Efficacy results from the ToGA trial: a phase III study of trastuzumab added to standard chemotherapy in first-line human epidermoid growth factor receptor 2 positive advanced cancer. J Clin Oncol 2009; (27 suppl), abstract ASCO Congress 2409.
22. Petrelli et al.: Clinical cancer cdvances 2009: Major research advances in cancer treatment, prevention and screening - a report from the American Society of Clinical Oncology - ASCO. J Clin Oncol 2009; 27: 1-18.
23. Okines A, Cunningham D: Trastuzumab in gastric cancer. Eur J Cancer 2010; 46: 1949-59.
24. Joørgensen JT. Targeted HER2 treatment in advanced gastric cancer. Oncology 2010; 78: 26-33.
25. New Hope for advanced gastric cancer - Lancet Oncology 2010; vol 11: 211
26. Popiela T i wsp.: Zasady leczenia raka żołâdka. "Polski konsensus" - ustalony w Krakowie w dniu 30 maja 1997. Pol Przegl Chir 1998; 70, suplement.